Carl Kohrt, vice president and general manager of Eastman Kodak'sHealth Sciences division, has found himself in privileged companyat the Rochester, NY, film giant. Kohrt joined chief executiveGeorge Fisher as one of three executives named to a new
Carl Kohrt, vice president and general manager of Eastman Kodak'sHealth Sciences division, has found himself in privileged companyat the Rochester, NY, film giant. Kohrt joined chief executiveGeorge Fisher as one of three executives named to a new chiefoperating office designed be the nucleus of Kodak's senior managementteam.
In announcing the moves last week, Fisher said the new teamwould handle the day-to-day operations of Kodak's global business.All the business, manufacturing, R&D and geographic regionsthat previously reported to other executives will report to thenew office. Kohrt will remain head of the Health Sciences unit.
Fisher will add COO to his titles of chairman, president andCEO, while Kohrt adds executive vice president and assistant COOto his resume. Joining Fisher and Kohrt on the team is DanielCarp, vice president and general manager of Kodak's European,African and Middle Eastern region.
Kodak said the moves were being made to strengthen the nextgeneration of Kodak's management team, making Kohrt and Carp automaticfront-runners in the event Fisher leaves the company.
Fisher was named to lead Kodak in 1993 and has dramaticallyincreased the company's focus on digital imaging (SCAN 4/12/94).He has said he intends to remain with the company at least throughhis current contract, which runs until 1998.
Kohrt, a 24-year Kodak veteran who has headed Health Sciencesfor four years, has led the division to increased worldwide marketshare despite an era of dramatic change and consolidation, Fishersaid.
"Carl Kohrt has defined Kodak's leadership in one of themost challenging markets in the world today, health care,"Fisher said.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.